For the Quarter Ending June 2026
Amlodipine Besylate Prices in North America
- In USA, the Amlodipine Besylate Price Index rose by 11.79% quarter-over-quarter due to regulatory delays.
- The average Amlodipine Besylate price for the quarter was approximately USD 76338.33/MT, CFR LA shipments.
- Amlodipine Besylate Spot Price firmed as Indian exporters raised offers, container freight elevated landed costs.
- Amlodipine Besylate Price Forecast shows modest volatility as replenishment offsets sporadic origin-side regulatory availability interruptions.
- Amlodipine Besylate Production Cost Trend remained stable for feedstock, while testing and compliance increased overhead.
- Amlodipine Besylate Demand Outlook stays steady as hospital restocking and routine prescriptions sustain baseline consumption.
- Amlodipine Besylate Price Index reacted to improved customs clearance and reduced port dwell easing bottlenecks.
- Major Indian and Chinese producers adjusted export allocations, tightening CFR Los Angeles availability, limiting volumes.
Why did the price of Amlodipine Besylate change in June 2026 in North America?
- Regulatory audits delayed Indian exports, reducing immediate supply and pressuring CFR LA landed prices.
- Container freight spikes raised landed costs, translating into firmer import offers despite steady domestic demand.
- Distributors replenished safety stocks after earlier destocking, supporting incremental import volumes and stable price support.
Amlodipine Besylate Prices in APAC
- In China, the Amlodipine Besylate Price Index rose by 11.7% quarter-over-quarter, driven by environmental inspections and export restocking.
- The average Amlodipine Besylate price for the quarter was approximately USD 76166.67/MT, reflecting elevated marginal costs.
- Tightened intermediates and compliance costs lifted the Amlodipine Besylate Spot Price and strengthened the Price Index.
- Amlodipine Besylate Price Forecast indicates near-term firmness as export inquiries and restocking support positive momentum.
- Rising benzene-linked feedstock costs influenced the Amlodipine Besylate Production Cost Trend, pressuring offers modestly in June.
- Strong overseas restocking improved the Amlodipine Besylate Demand Outlook, though domestic tendering limited incremental volume growth.
- Inventory draws at Shanghai bonded warehouses tightened prompt availability, supporting the Amlodipine Besylate Price Index upward bias.
- Major integrated plants sustained shipments, constraining spot supply while smaller solvent-recovery units paused, influencing Spot Price dynamics.
Why did the price of Amlodipine Besylate change in June 2026 in APAC?
- Environmental inspections curtailed solvent-recovery workshops, reducing intermediate availability and creating a short-term cost push effect.
- Accelerated overseas restocking absorbed export-ready lots, tightening prompt supply and lifting free-on-board quotations during quarter.
- Modest feedstock benzene price increases raised variable costs, supporting producer offers despite broadly stable inventories.
India
- In India, the Amlodipine Besylate Price Index rose by 23.98% quarter-over-quarter, driven by tight intermediates.
- Amlodipine Besylate Spot Price firmed on low inventories, supporting a higher Amlodipine Besylate Price Index.
Amlodipine Besylate Prices in Europe
- In Germany, the Amlodipine Besylate Price Index rose by 11.74% quarter-over-quarter, reflecting tighter import availability.
- The average Amlodipine Besylate price for the quarter was approximately USD 76310/MT delivered CFR Hamburg.
- Amlodipine Besylate Spot Price moderated as German inventories improved, reducing aggressive tender bidding and short-term purchasing.
- Amlodipine Besylate Price Forecast shows mild upside risk from elevated ocean freight and seasonal restocking by manufacturers.
- Amlodipine Besylate Production Cost Trend reflects higher solvent and documentation expenses, sustaining landed cost pressure for importers.
- Amlodipine Besylate Demand Outlook remains firm due to ageing population, stable prescriptions, and hospital procurement cycles.
- Amlodipine Besylate Price Index strength reflected Indian and Chinese supply shifts and contract manufacturers prioritising oncology molecules.
- Distributor inventories rose after May arrivals, easing urgent buying and tempering spot market volatility into June.
Why did the price of Amlodipine Besylate change in June 2026 in Europe?
- Ocean freight surge raised landed import costs, creating direct upward pressure on CFR Hamburg prices.
- Reallocation to oncology reduced Indian and Chinese export allocations, tightening immediate availability for German buyers.
- German tender competition and front-loaded hospital procurement sustained buying, supporting upward price bias in June.
For the Quarter Ending March 2026
Amlodipine Besylate Prices in APAC
- In China, the Amlodipine Besylate Price Index fell by 0.71% quarter-over-quarter, reflecting tighter export allocations.
- The average Amlodipine Besylate price for the quarter was approximately USD 68186.67/MT, FOB Shanghai reported.
- Amlodipine Besylate Spot Price tightened as solvent-recovery restrictions reduced merchant availability, supporting firmer short-term offers.
- Amlodipine Besylate Price Forecast indicates gradual increases driven by sustained export restocking and stock availability.
- Amlodipine Besylate Production Cost Trend rose as feedstock quotations for 2-chlorobenzaldehyde and benzenesulfonic acid increased.
- Amlodipine Besylate Demand Outlook remains firm with Indian and Brazilian buying before tenders supporting offtake.
- Inventory cover tightened to three weeks, influencing the Amlodipine Besylate Price Index and limiting selling.
- Major integrated plants maintained output while smaller tollers trimmed batches, keeping contracted shipments, firming offers.
Why did the price of Amlodipine Besylate change in March 2026 in APAC?
- Environmental inspections reduced solvent-recovery capacity, constraining halogenated intermediate supply and raising conversion costs and margins.
- Feedstock quotations rose, lifting production costs and allowing suppliers to raise FOB offers internationally consistently.
- Strong export demand from India and Brazil drew lots, prompting allocations and reducing inventory buffers.
Amlodipine Besylate Prices in Europe
- In Germany, the Amlodipine Besylate Price Index fell by 0.67% quarter-over-quarter, reflecting procurement responses to tightened spot supply.
- The average Amlodipine Besylate price for the quarter was approximately USD 68291.67/MT, reflecting import costs and procurement.
- Extended lead-times and quality audits tightened availability, lifting the Amlodipine Besylate Spot Price across import-dependent supply chains.
- Consensus Amlodipine Besylate Price Forecast points to modest gains as distributors replenish safety stocks amid constrained shipments.
- High energy and compliance expenses sustain an upward Amlodipine Besylate Production Cost Trend, supporting firmer landed quotations.
- Stable prescription volumes, tender cycles underpin a positive Amlodipine Besylate Demand Outlook across hospital and retail channels.
- Distribution firms elevated inventories in response to rail disruptions, supporting the Amlodipine Besylate Price Index at higher levels.
- Indian tender allocations and Chinese export-certificate audits diverted export volumes, constraining FOB availability and pressuring procurement timings.
Why did the price of Amlodipine Besylate change in March 2026 in Europe?
- Export diversions to domestic tenders in India reduced shipments to Europe, tightening prompt availability and lifting prices.
- Stricter export inspections and intermediate shortages increased lead-times, raising landed costs and pressuring procurement decisions.
- Rail disruptions at Hamburg prolonged clearance, prompting distributors to draw down safety stocks and accept higher offers.
Amlodipine Besylate Prices in North America
- In the USA, the Amlodipine Besylate Price Index fell by 0.69% quarter-over-quarter, reflecting tighter availability.
- The average Amlodipine Besylate price for the quarter was approximately USD 68290.00/MT, supported by demand.
- Amlodipine Besylate Spot Price tightened; cGMP audits slowed releases and reduced West Coast parcel availability.
- Amlodipine Besylate Price Forecast indicates modest gains as importers restock ahead of expected compliance delays.
- Amlodipine Besylate Production Cost Trend shows upward pressure from higher compliance and intermediate feedstock charges.
- Amlodipine Besylate Demand Outlook remains strong, supported by prescriptions, formulary placements, and chronic therapy consumption.
- Amlodipine Besylate Price Index volatility was limited by freight, LA port operations and inventory draws.
- Export demand and stocking tightened spot availability, supporting Amlodipine Besylate negotiations on short dated cargoes.
Why did the price of Amlodipine Besylate change in March 2026 in North America?
- Import availability tightened due to cGMP audits and an import alert, reducing West Coast shipments.
- Sustained prescription demand and formulary placement kept offtake steady, prompting distributors to replenish low inventories.
- Higher compliance costs plus freight surcharges modestly increased landed costs, translating into upward price pressure.
For the Quarter Ending December 2025
Amlodipine Besylate Price in North America
- In USA, the Amlodipine Besylate Price Index fell by 4.09% quarter-over-quarter, reflecting ample Asian supply.
- The average Amlodipine Besylate price for the quarter was approximately USD 68761.67/MT per CFR reports.
- Elevated inventories pressured the Amlodipine Besylate Spot Price as distributors offered CFR Los Angeles terms.
- Stable precursor costs kept the Amlodipine Besylate Production Cost Trend relatively flat despite freight normalization.
- Moderate prescription growth underpins the Amlodipine Besylate Demand Outlook but buying paused for inventory digestion.
- Monthly commentary supports a soft Amlodipine Besylate Price Forecast with limited upside absent supply disruptions.
- Port and logistics ease supported a lower Amlodipine Besylate Price Index, weighing on spot quotations.
- Export volumes from India and China drove downward pressure on the Amlodipine Besylate Spot Price.
Why did the price of Amlodipine Besylate change in December 2025 in North America?
- Surplus Asian exports and elevated U.S. inventories suppressed bids, promoting competitive discounting among distributors overall.
- Normalized freight and eased port congestion reduced landed costs, diminishing logistical price pressures for importers.
- Stable precursor prices and flat production costs limited cost-driven upside, leaving market sentiment predominantly bearish.
Amlodipine Besylate Price in APAC
- In China, the Amlodipine Besylate Price Index fell by 4.08% quarter-over-quarter, reflecting weaker export demand.
- The average Amlodipine Besylate price for the quarter was approximately USD 68673.33/MT, reflecting subdued buying.
- Amlodipine Besylate Spot Price softened as replenished inventories and normalized freight reduced urgency among buyers.
- The Amlodipine Besylate Price Forecast shows marginal upside from year-end restocking and occasional maintenance-driven tightness.
- Amlodipine Besylate Production Cost Trend remained neutral as feedstock availability and energy tariffs stayed unchanged.
- The Amlodipine Besylate Demand Outlook is muted with formulators deferring purchases and subdued international tendering.
- Rising merchant stocks pressured the Amlodipine Besylate Price Index while export enquiries from markets softened.
- Major east-coast producers maintained full schedules, while improved port turnaround eased some freight-related supply pressures.
Why did the price of Amlodipine Besylate change in December 2025 in APAC?
- Domestic plants ran without curbs and new continuous capacity increased merchant availability, creating supply pressure.
- Export enquiries softened as many buyers had covered Q1 needs earlier, reducing short-term spot interest.
- Freight cost volatility earlier and cautious formulators deferred restocking, prompting sellers to lower FOB offers.
Amlodipine Besylate Price in Europe
- In Germany, the Amlodipine Besylate Price Index fell by 4.11% quarter-over-quarter, reflecting ample imports and weak demand.
- The average Amlodipine Besylate price for the quarter was approximately USD 68755.00/MT, based on CFR Hamburg settlements and distributor inventories.
- Amlodipine Besylate Spot Price eased in December as large Asian shipments met year-end German distributor restocking.
- Amlodipine Besylate Price Forecast indicates modest recovery into January as buyers rebuild safety stocks post-holidays.
- Amlodipine Besylate Production Cost Trend remained contained as feedstock prices stayed stable while utilities pressured local manufacturers.
- Amlodipine Besylate Demand Outlook subdued, with hospitals and pharmacies deferring purchases after prior quarter front-loading.
- Working stocks rose, keeping Amlodipine Besylate Price Index pressured while logistics normalisation reduced short-term landed costs.
- Export demand provided limited support; competitive offers and distributor overhang drove negotiated CFR Hamburg quotations lower.
Why did the price of Amlodipine Besylate change in December 2025 in Europe?
- Large December shipments from India and China increased import availability, easing spot market tightness and pressuring prices.
- End-of-year distributor inventories remained elevated, reducing procurement urgency and limiting upward price momentum into December.
- Lower freight premiums and normalised port operations reduced landed costs, while statutory tender conclusions dampened spot buying.
For the Quarter Ending September 2025
North America
- In USA, the Amlodipine Besylate Price Index rose by 1.37% quarter-over-quarter, driven by importer frontloading.
- The average Amlodipine Besylate price for the quarter was approximately USD 71693.33/MT on CFR shipments.
- Amlodipine Besylate Spot Price displayed limited volatility despite import surges and intermittent port congestion periods.
- Amlodipine Besylate Price Forecast suggests modest gains as distributors replenish inventories cautiously over months ahead.
- Amlodipine Besylate Production Cost Trend rose due to higher freight, handling, and raw material costs.
- Amlodipine Besylate Demand Outlook remains steady with strategic forward buying sustaining near-term firm consumption levels.
- Distributor inventories tightened temporarily, pressuring the Amlodipine Besylate Price Index across major US distribution hubs.
- Logistics disruptions and seasonal congestion increased landed costs, prompting sellers to sustain firm pricing levels.
Why did the price of Amlodipine Besylate change in September 2025 in North America?
- Importer frontloading ahead of tariff uncertainty concentrated orders, creating short-term demand spikes and market tightening.
- Rising freight and handling costs elevated landed costs, supporting higher domestic pricing and supplier margins.
- Port congestion and weather disruptions delayed shipments, reducing immediate supply availability and amplifying distribution bottlenecks.
APAC
- In China, the Amlodipine Besylate Price Index rose by 1.426% quarter-over-quarter in Q3 2025, frontloaded export activity.
- The average Amlodipine Besylate price for the quarter was approximately USD 71596.67/MT, FOB Shanghai levels.
- Amlodipine Besylate Spot Price firmed on tightened logistics and stronger export orders, reducing available spot market volumes.
- Amlodipine Besylate Price Forecast indicates gradual increases through late autumn as frontloaded shipments normalize and inventories adjust.
- Amlodipine Besylate Production Cost Trend rose with higher freight rates and weather-related operational disruptions raising unit supply costs.
- Amlodipine Besylate Demand Outlook remains supportive due to international restocking and advanced orders ahead of tariff reinstatement.
- Amlodipine Besylate Price Index volatility moderated as exporters drew down June–August stocks, easing near-term supply pressures.
- Port congestion and vessel space shortages intermittently pushed small spot price spikes and encouraged aggressive booking by exporters.
- Manufacturers kept output conservative, avoiding capacity expansion while aligning batches for holidays, supporting modest sustained price increases.
Why did the price of Amlodipine Besylate change in September 2025 in APAC?
- Frontloaded export orders increased short-term demand, tightening availability and prompting suppliers to raise prices slightly.
- Rising ocean freight rates and port congestion elevated logistics costs, pushing up delivered production prices.
- Temporary tariff suspension accelerated shipments; once suspension ends, buying patterns likely to normalize, reducing urgency.
Europe
- In Germany, the Amlodipine Besylate Price Index rose by 1.44% quarter-over-quarter, driven by port congestion.
- The average Amlodipine Besylate price for the quarter was approximately USD 71700.00/MT as reported locally.
- Amlodipine Besylate Spot Price tightened as early restocking and freight surcharges reduced available spot volumes.
- Amlodipine Besylate Price Forecast shows modest near-term gains as logistics improve and demand stabilizes seasonally.
- Amlodipine Besylate Production Cost Trend remains stable with limited feedstock inflation and higher transport-related overheads.
- Amlodipine Besylate Demand Outlook is steady with cautious restocking by wholesalers and healthcare providers nationwide.
- Amlodipine Besylate Price Index reflected tight inventories and constrained exports amid berth delays and rerouting.
- Adjusted carrier schedules ease shipments, fostering supply normalization and reducing short-term price volatility overcoming delays.
Why did the price of Amlodipine Besylate change in September 2025 in Europe?
- Persistent Northern European port congestion prolonged berth times, delaying shipments and tightening local supply availability.
- Elevated freight surcharges and rerouting increased landed costs and lead times, pressuring procurement and margins.
- Advance restocking by wholesalers and healthcare providers reduced spot availability, amplifying short-term upward price pressure.
